TWD 33.45
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 2.11 Billion TWD | 16.06% |
2022 | 1.82 Billion TWD | 42.11% |
2021 | 1.28 Billion TWD | 13.44% |
2020 | 1.13 Billion TWD | 46.02% |
2019 | 775.97 Million TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 576.47 Million TWD | 1.51% |
2024 Q1 | 567.91 Million TWD | 3.2% |
2023 Q4 | 550.28 Million TWD | 8.27% |
2023 FY | 2.11 Billion TWD | 16.06% |
2023 Q3 | 508.25 Million TWD | -7.72% |
2023 Q2 | 550.74 Million TWD | 7.85% |
2023 Q1 | 510.65 Million TWD | 1.78% |
2022 FY | 1.82 Billion TWD | 42.11% |
2022 Q4 | 501.7 Million TWD | 0.0% |
2021 FY | 1.28 Billion TWD | 13.44% |
2020 FY | 1.13 Billion TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Allied Biotech Corporation | 246.43 Million TWD | -760.225% |
GeneFerm Biotechnology Co., Ltd. | 286.35 Million TWD | -640.325% |
Easywell Biomedicals, Inc. | 170.71 Million TWD | -1141.772% |
TTY Biopharm Company Limited | 3.22 Billion TWD | 34.239% |
Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | 1.271% |
Center Laboratories, Inc. | 618.09 Million TWD | -242.978% |
Tien Liang BioTech Co., Ltd. | 286.14 Million TWD | -640.851% |
Orient Pharma Co., Ltd. | 468.66 Million TWD | -352.332% |
InnoPharmax Inc. | 17.45 Million TWD | -12043.719% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | -766.575% |
Excelsior Biopharma Inc. | 306.93 Million TWD | -590.688% |
DV Biomed Co., Ltd. | 764.27 Million TWD | -177.377% |
Foresee Pharmaceuticals Co., Ltd. | 113.97 Million TWD | -1760.044% |
Handa Pharmaceuticals, Inc. | 1.1 Billion TWD | -91.845% |
UniPharma Co., Ltd. | 51.01 Million TWD | -4055.42% |
Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | -434.076% |
Alar Pharmaceuticals Inc. | 465.92 Million TWD | -354.998% |
Winston Medical Supply Co., Ltd. | 347.59 Million TWD | -509.88% |
Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -357996.115% |
Bioray Biotech Co., Ltd | 77.65 Million TWD | -2630.073% |
TSH Biopharm Corporation Limited | 399.89 Million TWD | -430.116% |